Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies
about
Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyPI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicityThe staphylococcal enterotoxin (SE) family: SEB and siblingsMonoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin DrugsStructural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding siteAntibodies for biodefenseThe potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology.Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates.Neutralising antibodies against ricin toxin.Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B.Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodiesMonoclonal antibodies and toxins--a perspective on function and isotype.Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions.Bacterial Toxins-Staphylococcal Enterotoxin B.Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics.FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights.Automated nanoscale flow cytometry for assessing protein-protein interactions.Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.Optimization of experimental conditions for functional in vitro characterization of humanized antibodies specific for staphylococcal enterotoxin B.A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.Staphylococcus aureus toxin antibodies: Good companions of antibiotics and vaccines.
P2860
Q26752975-6DBE0A18-D7BD-4E2D-A747-00C0768A5CE0Q26825729-7CC9CF6F-D853-4BBE-A1B8-16E5C611C5B3Q26830220-2BD30F3B-D6F1-493F-9E69-3DABA7F4C401Q26863621-F960123C-1016-4CFD-8F74-DC80510941C6Q27681324-39122828-0DD8-47F4-9BAF-F2CE0AA3AFF4Q28394941-6B21709D-FDA8-4160-AC48-215AEB6D1D27Q30415990-D20DEA64-C16B-47E5-AEA9-3F002F506B62Q33646942-71690506-85C2-4F37-AD6C-ADBA6419CC17Q33719201-92786753-0056-49C9-9D3C-B2D1FE3EE848Q33751822-7A529CD8-B9B0-424B-A578-2EC85A91CCBBQ33899955-B1A5CCA0-B9C6-414F-A192-C39CBC237F0FQ33919740-B3A8895A-A903-4C94-B700-2604D7EA2889Q34079264-F4968CAA-D32C-48CD-A7F5-D2917CCAC5A1Q34498690-50BC52E5-9119-4B0C-AB78-35A38D22093BQ35172579-8EF6CABF-F184-4600-8790-88103D3E371AQ36099489-8C759337-526A-4BF7-A289-36704EA61DCEQ37235247-AFE91CF3-9FF5-4B47-82A0-12C97B07C00EQ37378451-7FAD2B7A-042C-42B3-B337-55F6B788A07FQ39022323-D5FE5758-F44C-462E-B931-D41F32FDEE7AQ39301452-7EE36FFB-63BA-4C8B-AFD3-D7B63621B2C1Q39432301-283D99A6-7D20-469A-816E-E5CA77D4AB4FQ40420550-CA65DD0E-D68D-4500-B262-901AA3B167FCQ41129982-7BE36F67-F317-40B3-BDA8-74C5303D956BQ42376180-E45DE7E5-1092-4ED9-BD9C-50AD41149688Q55057062-00202396-C4CA-4DB0-8D89-A41D7B8D2524
P2860
Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Potent neutralization of staph ...... action of chimeric antibodies
@ast
Potent neutralization of staph ...... action of chimeric antibodies
@en
type
label
Potent neutralization of staph ...... action of chimeric antibodies
@ast
Potent neutralization of staph ...... action of chimeric antibodies
@en
prefLabel
Potent neutralization of staph ...... action of chimeric antibodies
@ast
Potent neutralization of staph ...... action of chimeric antibodies
@en
P2093
P2860
P356
P1476
Potent neutralization of staph ...... action of chimeric antibodies
@en
P2093
Ashenafi Y Tilahun
Barbara A Osborne
David I Ratner
Govindarajan Rajagopalan
Kannan Natarajan
Mulualem E Tilahun
Nalini Shah-Mahoney
Rebecca G Lawlor
Richard A Goldsby
P2860
P304
P356
10.1128/IAI.01121-09
P407
P577
2010-03-22T00:00:00Z